Try a new search

Format these results:

Searched for:

in-biosketch:true

person:crb253

Total Results:

122


Slow pathway modification for treatment of pseudo-pacemaker syndrome due to first-degree atrioventricular block with dual atrioventricular nodal physiology

Lader, Joshua M; Park, David; Aizer, Anthony; Holmes, Douglas; Chinitz, Larry A; Barbhaiya, Chirag R
PMCID:5919070
PMID: 29707483
ISSN: 2214-0271
CID: 3056812

Esophageal Injury and Atrioesophageal Fistula Caused by Ablation for Atrial Fibrillation

Kapur, Sunil; Barbhaiya, Chirag; Deneke, Thomas; Michaud, Gregory F
Esophageal perforation is a dreaded complication of atrial fibrillation ablation that occurs in 0.1% to 0.25% of atrial fibrillation ablation procedures. Delayed diagnosis is associated with the development of atrial-esophageal fistula (AEF) and increased mortality. The relationship between the esophagus and the left atrial posterior wall is variable, and the esophagus is most susceptible to injury where it is closest to areas of endocardial ablation. Esophageal ulcer seems to precede AEF development, and postablation endoscopy documenting esophageal ulcer may identify patients at higher risk for AEF. AEF has been reported with all modalities of atrial fibrillation ablation despite esophageal temperature monitoring. Despite the name AEF, fistulas functionally act 1 way, esophageal to atrial, which accounts for the observed symptoms and imaging findings. Because of the rarity of AEF, evaluation and validation of strategies to reduce AEF remain challenging. A high index of suspicion is recommended in patients who develop constitutional symptoms or sudden onset chest pain that start days or weeks after atrial fibrillation ablation. Early detection by computed tomography scan with oral and intravenous contrast is safe and feasible, whereas performance of esophageal endoscopy in the presence of AEF may result in significant neurological injury resulting from air embolism. Outcomes for esophageal stenting are poor in AEF. Aggressive intervention with skilled cardiac and thoracic surgeons may improve chances of stroke-free survival for all types of esophageal perforation.
PMID: 28947480
ISSN: 1524-4539
CID: 2717682

Utilization of a radiation safety time out significantly reduces radiation exposure during electrophysiology procedures [Meeting Abstract]

Aizer, A; Cheng, A V; Wu, P; Holmes, D; Fowler, S J; Bernstein, S A; Park, D S; Wagner, S R; Barbhaiya, C R; Chinitz, L A
Background: Pre-procedure time outs are integral to medicine to improve quality and safety. We hypothesized that a radiation safety time out for EP procedures would reduce radiation exposure levels for patients and staff. Objective: To design, implement and assess the effect of a radiation safety time out on radiation exposure in the EP lab. Methods: Baseline data on all adult EP procedures were collected for 6 months prior to implementation of the radiation safety time out. Upon implementation of the time out, data were collected prospectively with analyses to be performed every 3 months for up to 12 months. The primary endpoint was mean dose area product (DAP). Secondary endpoints were reference dose, fluoroscopy time, use of additional shielding, and use of alternative imaging. Results: The study was halted after three months. In total, 592 cases prior to the time out and 448 cases during implementation of the time out were included. Use of the time out resulted in a 22% reduction in the DAP (p = 0.013). The mean reference dose was also reduced by 26%. The use of additional radiation shields and ultrasound imaging for venous access increased significantly during the time out period. These differences remained significant when adjusted for BMI, proceduralist, and procedure type. There was no increase in procedure time or complications with the time out (Table). Conclusion: Implementation of a radiation safety time out significantly reduces radiation exposure during EP procedures. EP laboratories, as well as other areas of medicine that use fluoroscopy, should strongly consider the use of radiation safety time outs to reduce radiation exposures and improve safety. (Table presented)
EMBASE:617042238
ISSN: 1556-3871
CID: 2620902

Comparison of Wilson central terminal and IVC indifferent electrode for unipolar mapping of idiopathic outflow tract premature ventricular contractions [Meeting Abstract]

Barbhaiya, C R; Fowler, S; Bernstein, S A; Park, D S; Holmes, D; Aizer, A; Chinitz, L A
Background: Analysis of the local unipolar electrogram aids premature ventricular contraction (PVC) localization in catheter ablation of idiopathic, outflow tract PVCs. A unipolar electrogram QS complex may be seen in the region of PVC origin, but the specificity of this finding is low. The unipolar anodal electrode utilized for PVC mapping is typically Wilson central terminal (WCT) or an indifferent electrode placed within the inferior vena cava (IVC). The optimal unipolar electrode selection for unipolar PVC mapping is unknown. Objective: To compare unipolar mapping of idiopathic outflow tract PVCs using WCT to unipolar mapping using an IVC electrode. Methods: PVC mapping and ablation was performed in 20 consecutive patients presenting for first-time ablation of idiopathic, outflow tract PVCs. The unipolar electrode utilized for initial mapping was randomly assigned and blinded to the operator. Mapping was performed using the CARTO 3 mapping system and SmartTouch RF ablation catheter (Biosense Webster, Inc.). Activation mapping and pace-mapping was performed at the discretion of the operator. Locations with a QS complex were annotated on the electroanatomic map. After a complete map was created blinded mapping was repeated with the alternate unipolar electrode prior to RF application. Results: PVCs were localized to the right ventricular outflow tract in 18 patients (90%) and to the left ventricular outflow tract in 2 patients (10%). Complete unipolar mapping could not be completed in 4 of 20 (20%) of cases due to infrequency of PVCs. In the 16 remaining patients, QS complex surface area was significantly larger with WCT than with the IVC electrode (3.11 +/- 1.8 cm2 vs. 1.3 +/- 0.8 cm2, p < 0.001). The IVC electrode QS area was completely within the WCT QS area in all cases, and the ratio of WCT QS area to IVC electrode QS area was 2.6 +/- 0.8 (range 1.8 to 4.4). The area of RF application at which PVCs were durably suppressed was within the IVC electrode QS area in all patients. Conclusion: Utilization of an indifferent IVC electrode may improve precision and specificity of unipolar mapping in catheter ablation of idiopathic, outflow tract PVCs
EMBASE:617041256
ISSN: 1556-3871
CID: 2620952

Left atrial posterior wall isolation compared to stepwise linear ablation for nonparoxysmal atrial fibrillation using a contact force sensing radiofrequency ablation catheter [Meeting Abstract]

Knotts, R J; Barbhaiya, C R; Bockstall, K E; Bernstein, S A; Park, D S; Fowler, S J; Holmes, D; Aizer, A; Chinitz, L A
Background: Unfavorable outcomes observed with stepwise linear ablation of non-paroxysmal AF (NPAF) in large clinical trials utilizing ablation catheters without contact-force sensing (CFS) may be attributable to pro-arrhythmic effects of incomplete ablation lines. The optimal ablation strategy for catheter ablation of NPAF using a contact force sensing radiofrequency (RF) ablation catheter remains unclear. Objective: To compare catheter ablation outcomes of stepwise linear ablation to left atrial (LA) posterior wall isolation in patients undergoing NPAF ablation using a CFS RF ablation catheter. Methods: We performed pulmonary vein antral isolation (PVAI) followed by isolation of the LA posterior wall in 80 consecutive patients undergoing first-time NPAF ablation between November 2015 and March 2016 (Group 1) and compared clinical outcomes to those of 112 consecutive patients who underwent PVAI followed by step-wise linear ablation for NPAF between May 2014 and November 2015 (Group 2). All ablation procedures were performed using the Carto 3 mapping system and SmartTouch RF ablation catheter (Biosense Webster, Inc.). Arrhythmia recurrence was assessed using 2-week event monitors at 3-month intervals. Arrhythmia-free survival at 12 months was estimated using the Kaplan-Meier method. Results: Baseline characteristics of Group 1 and Group 2 were similar. At 12 months follow-up, arrhythmia-free survival was significantly greater in Group 1 patients compared with Group 2 (81.9% vs. 67.5%, respectively; p=0.0318). There was no significant difference in survival free from AF between group 1 and group 2 (89% vs. 84.1%, respectively; p=0.3431), however group 1 patients developed significantly fewer post-ablation atrial tachycardias (AT) than group 2 patients (8.1% vs 30.1%, respectively; p<0.001). Conclusion: Among patients undergoing NPAF ablation using a contact force sensing RF ablation catheter, LA posterior wall isolation resulted in fewer recurrent atrial arrhythmias than a stepwise linear approach. The reduction in recurrent atrial arrhythmias is driven primarily by a reduction in recurrent AT
EMBASE:617041092
ISSN: 1556-3871
CID: 2623582

GENETIC TESTING FOR DIAGNOSIS OF PROGRESSIVE CARDIAC CONDUCTION DISEASE [Meeting Abstract]

Guandalini, Gustavo; Park, David; Pan, Stephen; Barbhaiya, Chirag; Axel, Leon; Fowler, Steven; Cerrone, Marina; Chinitz, Larry
ISI:000397342303205
ISSN: 1558-3597
CID: 2528942

Determinants of Heparin Dosing and Complications in Patients Undergoing Left Atrial Ablation on Uninterrupted Rivaroxaban

Enriquez, Alan D; Churchill, Timothy; Gautam, Sandeep; Chinitz, Jason S; Barbhaiya, Chirag R; Kumar, Saurabh; John, Roy M; Tedrow, Usha B; Koplan, Bruce A; Stevenson, William G; Michaud, Gregory F
BACKGROUND: Patients on rivaroxaban have variable INRs, but it is uncertain if INR impacts procedural heparin requirement during left atrial ablation. We sought to examine the determinants of heparin dosing in this patient population. METHODS: We reviewed consecutive patients who received rivaroxaban within 24 hours of left atrial ablation and compared them to patients on uninterrupted warfarin. The determinants of heparin requirement were evaluated using regression analysis. We then tested a weight based heparin dose prospectively in rivaroxaban patients. RESULTS: There were 258 patients on rivaroxaban and 213 on warfarin. The mean INR was 1.4 in the rivaroxaban group and 2.3 in the warfarin group (p<0.01). To achieve an activated clotting time (ACT) >350 seconds, rivaroxaban patients required significantly more heparin (166.9 vs. 78.3 units/kg, p<0.001). In the rivaroxaban group, body weight was the strongest predictor of heparin dose (r = 0.52) while INR was weakly correlated (r = -0.21). In the prospective group, 25 patients were given an initial heparin dose of 120 units/kg with 22/25 (88%) achieving an ACT >300 seconds. There were 7 and 3 cases of pericardial effusion in rivaroxaban and warfarin patients, respectively (p = 0.41). The average volume drained in the rivaroxaban group was elevated (988.6 vs. 275.0 milliliters, (p = 0.21). CONCLUSIONS: Body weight is the strongest predictor of procedural heparin requirement during left atrial ablation in patients on uninterrupted rivaroxaban, even in those with an elevated INR. A heparin dose of 120 units/kg achieves an ACT >300 seconds in the majority of patients. In cases of pericardial effusion, bleeding may be prolonged
PMID: 28054374
ISSN: 1540-8159
CID: 2386782

Recurrence of Atrial Arrhythmias Despite Persistent Pulmonary Vein Isolation After Catheter Ablation for Atrial Fibrillation: A Case Series

Baldinger, Samuel H; Chinitz, Jason S; Kapur, Sunil; Kumar, Saurabh; Barbhaiya, Chirag R; Fujii, Akira; Romero, Jorge; Epstein, Laurence M; John, Roy; Tedrow, Usha B; Stevenson, William G; Michaud, Gregory F
OBJECTIVES/OBJECTIVE:The aim of this study was to categorize arrhythmia mechanisms and to summarize ablation strategies in patients with persistent pulmonary vein isolation (PVI) at the time of redo procedures. BACKGROUND:Persistent PVI is more frequently seen in patients undergoing redo procedures for recurrent atrial arrhythmias after catheter ablation for atrial fibrillation (AF). METHODS:Consecutive patients who underwent their first AF ablation procedures at Brigham and Women's Hospital were screened and included if they had persistent isolation of all pulmonary veins at the time of redo procedures. RESULTS:Of 300 consecutive patients undergoing first AF ablation procedures, redo procedures were performed in 63 (21%), and 26 patients (9%) had persistent PVI. Of those, 11 had recurred with AF and 15 with organized atrial tachycardia (AT). During the index procedure, linear ablation was performed in 46% of patients with recurrent AF and 93% with recurrent organized AT (p = 0.020). At the time of last follow-up, 2 of 10 patients (20%) in the AF group and 10 of 15 patients (67%) in AT group were in sinus rhythm, without class I or III antiarrhythmic drugs (p = 0.022). CONCLUSIONS:Patients with recurrence of atrial arrhythmia despite persistent PVI frequently present with organized AT. Linear ablation during the index procedure is associated with recurrence of organized AT. Recurrence rates after redo procedures were higher if patients had recurrent AF after the index procedure, and these patients often presented with AF again. Patients with recurrent AF despite persistent PVI may represent a population with lower success rates of catheter ablation.
PMID: 29759751
ISSN: 2405-5018
CID: 3234712

Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease

Kumar, Saurabh; Romero, Jorge; Mehta, Nishaki K; Fujii, Akira; Kapur, Sunil; Baldinger, Samuel H; Barbhaiya, Chirag R; Koplan, Bruce A; John, Roy M; Epstein, Laurence M; Michaud, Gregory F; Tedrow, Usha B; Stevenson, William G
BACKGROUND:Long-term outcomes after ventricular tachycardia (VT) ablation are sparsely described. OBJECTIVES:The purpose of this study was to describe long-term prognosis after VT ablation in patients with no structural heart disease (no SHD), ischemic cardiomyopathy (ICM), and nonischemic cardiomyopathy (NICM). METHODS:Consecutive patients (N = 695: no SHD, 98; ICM, 358; NICM, 239) ablated for sustained VT were followed for a median of 6 years. Acute procedural parameters (complete success [noninducibility of any VT]) and outcomes after multiple procedures were reported. RESULTS:Compared with patients with no SHD or NICM, patients with ICM were the oldest, were more likely to be men, lowest left ventricular ejection fraction, highest drug failures, VT storms, and number of inducible VTs. Complete procedure success was highest in patients with no SHD than in patients with ICM and those with NICM (79%, 56%, 60%, respectively; P < .001). At 6 years, ventricular arrhythmia (VA)-free survival was highest in patients with no SHD (77%) than in patients with ICM (54%) and those with NICM (38%) (P < .001), and overall survival was lowest in patients with ICM (48%), followed by patients with NICM (74%) and patients with no SHD (100%) (P < .001). Age, left ventricular ejection fraction, presence of SHD, acute procedural success (noninducibility of any VT), major complications, need for nonradiofrequency ablation modalities, and VA recurrence were independently associated with all-cause mortality. CONCLUSION:Long-term follow-up after VT ablation shows excellent prognosis in the absence of SHD, highest VA recurrence, and transplantation in patients with NICM and highest mortality in patients with ICM. The extremely low mortality for those without SHD suggests that VT in this population is rarely an initial presentation of a myopathic process.
PMID: 27392945
ISSN: 1556-3871
CID: 3106482

Determinants of lesion size variability in force-time-integral guided atrial radiofrequency ablation [Meeting Abstract]

Barbhaiya, C R; Kumar, S; Baldinger, S H; Ashton, J; Michaud, G F
Introduction: Use of contact force sensing ablation catheters and automated lesion annotation software has improved reliability of radiofrequency (RF) ablation lesion creation. Predictors of poor lesion creation despite adequate contact force and power are not well understood. Methods: Discrete biatrial lesions were created in 9 in vivo porcine hearts with a power of 30 W using a contact force sensing, 3.5 mm irrigated ablation catheter (SmartTouch, Biosense Webster). Lesion location was tagged using a 3D mapping system (Carto 3, Biosense Webster). Lesion duration was guided by Force Time Integral = 400 g*s using an automated lesion annotation system (VisiTag, Biosense Webster). Transmurality of ablation lesions and lesion dimensions were assessed grossly after TTC staining. The length and width of each lesion was measured on the endocardium and epicardium, and the smallest dimension was designated the minimum transmural diameter (MTD). Nontransmural lesions and lesions that could not be found were assigned a MTD of 0 mm. Results: Thirty-five discrete lesions created in non-trabeculated atrial tissue were correlated to lesions on the 3D map. There were 21 lesions with MTD>5mm(5.7+/-0.4mm, Group1) and 14lesions with MTD < 5 mm (4.5 +/- 0.3 mm, Group 2). Group 1 and group 2 lesions had similar FTI (428.5 +/-18.9 g*s vs. 426.8 +/-15.3 g*s, p = 0.78), Force Power Time Integral (4.5 +/- 0.3 cm vs. 4.4 +/- 0.5 cm, p=0.4), and RF duration (25.7 +/- 8.9 s vs. 25.2 +/- 5.7 s, p=0.85). While there was no difference in total impedance decrease between group 1 and group 2 (29.6 +/-15.2Q vs. 25.7 +/-10.0 Q, p=0.4), Group 1 lesions had a greater impedance decrease at 15s (33.4+/-13.9 O. vs. 24.0+/-9.0 O., p=0.03). In addition, group 1 lesions achieved a higher average temperature (43.0 +/- 5.3 degreeC vs. 39.3.7 +/- 5.2degreeC, p<0.05) and were created with a smaller catheter-tissue angle (54.1 +/- 21.1degree vs. 71.4 +/- 22.8degree, p=0.03). Conclusions: Automated lesion annotation technology based solely on contact force, RF duration, and RF power does not reliably predict lesion size in smooth, atrial tissue. Consideration of impedance decrease at 15s, average electrode temperature, and catheter-tissue angle may improve predictive accuracy of automated lesion annotation
EMBASE:72283893
ISSN: 1556-3871
CID: 2150952